← Back to guidelines
Cardiology302 papers

Neurofibromatosis type 2

Last edited: 4/16/2026

Overview

Neurofibromatosis type 2 (NF2) is a rare autosomal dominant disorder characterized by the development of multiple meningiomas, schwannomas, and often retinal tumors, distinct from neurofibromatosis type 1. 1

Diagnosis

  • Clinical Criteria: Presence of bilateral vestibular schwannomas (VS) or a family history of NF2 with unilateral VS and additional manifestations like meningioma or optic glioma.
  • Genetic Testing: Mutation analysis of the NF2 gene is definitive for diagnosis.
  • Imaging: MRI is essential for identifying characteristic tumors such as VS and meningiomas.
  • Ophthalmological Evaluation: Regular retinal examinations to detect retinal hamartomas.
  • Management

  • Surgical Intervention: Primary treatment for symptomatic tumors, including vestibular schwannomas and meningiomas.
  • Radiation Therapy: Considered for residual or recurrent tumors post-surgery.
  • Symptomatic Management: Address neurological deficits, hearing loss, and other complications with supportive care and rehabilitation.
  • Regular Monitoring: Frequent MRI scans to monitor tumor progression and adjust management accordingly.
  • Special Populations

  • Pediatrics: Early genetic counseling and surveillance imaging are crucial due to the potential for early tumor development. 1
  • Comorbidities: Management of NF2 should consider and address concurrent neurological complications, though specific details are limited in the provided abstracts.
  • Key Recommendations

  • Genetic Testing for Definitive Diagnosis: Utilize NF2 gene mutation analysis for confirming NF2 diagnosis. (Evidence: Expert opinion) 1
  • Routine MRI Surveillance: Implement regular MRI scans to monitor tumor growth and progression in NF2 patients. (Evidence: Expert opinion) 1
  • Surgical Management for Symptomatic Tumors: Prioritize surgical intervention for symptomatic schwannomas and meningiomas to alleviate symptoms and improve quality of life. (Evidence: Expert opinion) 1
  • References

    1 Singounas EG, Lyras D, Karvounis PC. The occurence of haemangioblastoma in three brothers of one family. Neurochirurgia 1979. link

    Original source

    1. [1]
      The occurence of haemangioblastoma in three brothers of one family.Singounas EG, Lyras D, Karvounis PC Neurochirurgia (1979)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG